Koninklijke Philips (PHG) Net Cash Flow Growth (5y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -22.23% |
| Dec 31, 2025 | 50.49% |
| Sep 30, 2025 | -17.85% |
| Jun 30, 2025 | -21.79% |
| Mar 31, 2025 | -51.54% |
| Dec 31, 2024 | 17.88% |
| Sep 30, 2024 | -29.43% |
| Jun 30, 2024 | 19.41% |
| Mar 31, 2024 | -102.46% |
| Dec 31, 2023 | 28.83% |
| Sep 30, 2023 | 11.55% |
| Jun 30, 2023 | 18.42% |
| Mar 31, 2023 | 13.92% |
| Dec 31, 2022 | 23.36% |
| Sep 30, 2022 | 39.40% |
| Jun 30, 2022 | -9.98% |
| Mar 31, 2022 | -22.84% |
| Dec 31, 2021 | -3.52% |
| Sep 30, 2021 | 39.17% |
| Jun 30, 2021 | -17.40% |
| Mar 31, 2021 | 24.46% |
| Dec 31, 2020 | 16.78% |
| Sep 30, 2020 | 21.39% |
| Jun 30, 2020 | 22.54% |
| Mar 31, 2020 | 27.93% |
| Dec 31, 2019 | -4.34% |
| Jun 30, 2018 | 4.73% |
| Mar 31, 2018 | 16.14% |
| Dec 31, 2017 | -50.49% |
| Sep 30, 2017 | -63.26% |
| Jun 30, 2017 | 11.14% |
| Mar 31, 2017 | -26.66% |
| Dec 31, 2016 | -14.84% |
| Sep 30, 2016 | 53.29% |
| Jun 30, 2016 | 14.14% |
| Mar 31, 2016 | 18.49% |
| Dec 31, 2015 | -16.82% |
| Sep 30, 2015 | -53.75% |
| Jun 30, 2015 | -226.12% |
| Mar 31, 2015 | -24.04% |
| Dec 31, 2014 | -91.50% |